{"product_id":"penn-medicine-the-mark-e-josephson-thirtieth-annual-state-of-the-art-arrhythmia-symposium-2023","title":"Penn Medicine The Mark E. Josephson Thirtieth Annual State-of-the-Art Arrhythmia Symposium 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"product_title entry-title\"\u003ePenn Medicine The Mark E. Josephson Thirtieth Annual State-of-the-Art Arrhythmia Symposium 2023\u003c\/h3\u003e\n\u003cp\u003eArt Arrhythmia Symposium\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Include: 35 videos + 36 pdfs, size: 21.9 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003eSaturday, September 9, 2023, 7:30 AM – 5:00 PM, Hilton Philadelphia at Penn’s Landing, Philadelphia, PA\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cp\u003eArt Arrhythmia Symposium This is the 30th year for the State of the Art Arrhythmia Symposium. Using a combination of case presentations with audience participation, didactic presentations, and question and answer sessions, our goal is to educate the participants in state of the art information on invasive and non-invasive electrophysiologic and electrocardiographic tools used in the current diagnosis, evaluation and treatment of cardiac rhythm disorders.\u003c\/p\u003e\n\u003cp\u003eArt Arrhythmia Symposium The program is taught by members of the faculty and staff from the University of Pennsylvania Health System, Department of Electrophysiology, in addition to invited speakers from other institutions. The course is structured to meet the educational needs of electrophysiologists, cardiologists, internists, nurses, and associated professionals with an interest in the care of patients with cardiac rhythm disorders.\u003c\/p\u003e\n\u003cp\u003eArt Arrhythmia Symposium In addition to the morning session with lectures aimed at the entire audience, there are three breakout sessions in the afternoon aimed at 1) associated professionals 2) general cardiology and 3) an advanced electrophysiology session aimed at EP fellows, electrophysiologists, and EP lab staff. The State of the Art Symposium is coupled each year with the Leonard N. Horowitz Memorial Lecture which is given by a leader in cardiology.\u003c\/p\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – INTERNAL MEDICINE – Clinical Cardiac Electrophysiology, INTERNAL MEDICINE – Interventional Cardiology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eArt Arrhythmia Symposium\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003e\u003cem\u003eAfter completing this activity, participants should be able to:\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDescribe the appropriate evaluation of patients with frequent PVCs as well as indications for treatment including ablation and antiarrhythmic medications\u003c\/li\u003e\n\u003cli\u003eDiscuss the differences in the various oral anticoagulants including appropriate use, dosing, risks, and contraindications.\u003c\/li\u003e\n\u003cli\u003eRecognize ECG clues to detect patients at risk for sudden death.\u003c\/li\u003e\n\u003cli\u003eDescribe new treatment for patients presenting with neurocardiogenic syncope.\u003c\/li\u003e\n\u003cli\u003eApply in practice the newest information regarding evaluation and treatment of atrial arrhythmias including screening for episodes and ablation indications, techniques, and endpoints\u003c\/li\u003e\n\u003cli\u003eDescribe the indications for cardiac resynchronization therapy and conduction system pacing, based on QRS morphology and duration, symptoms, functional class, ejection fraction, and type of heart disease\u003c\/li\u003e\n\u003cli\u003eReview the indications, contraindications, and complications associated with left atrial (LA) appendage occlusion and closure\u003c\/li\u003e\n\u003cli\u003eAssess the methods, techniques, associated tools, and equipment including emerging technologies to perform to catheter ablation of atrial fibrillation and flutter\u003c\/li\u003e\n\u003cli\u003eDescribe how to manage bleeding in patients on oral anticoagulation including choice of reversal agents and consequences of reversing anticoagulation\u003c\/li\u003e\n\u003cli\u003eDiscuss methods to manage pain around EP procedures to avoid overuse of opioids\u003c\/li\u003e\n\u003cli\u003eRecognize use and value of new techniques and technologies employed for complex EP device and ablation cases.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003eArt Arrhythmia Symposium\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e4D ICE Direct LA LV – Images and Clinical Utility.mp4\u003cbr\u003e\n4D ICE Direct LA LV – Images and Clinical Utility.pdf\u003cbr\u003e\nAlcohol Venous Ablation for Atrial and Ventricular Arrhythmias.mp4\u003cbr\u003e\nAlcohol Venous Ablation for Atrial and Ventricular Arrhythmias.pdf\u003cbr\u003e\nAnesthesia and Pain Management During and After EP Procedures- Important Considerations to Eliminate Pain but Not Overmedicate.mp4\u003cbr\u003e\nAnesthesia and Pain Management During and After EP Procedures- Important Considerations to Eliminate Pain but Not Overmedicate.pdf\u003cbr\u003e\nAvoiding Intravenous Pacemaker and ICD Leads.mp4\u003cbr\u003e\nAvoiding Intravenous Pacemaker and ICD Leads.pdf\u003cbr\u003e\nCardiac Resynchronization Stimulation for Heart Failure.mp4\u003cbr\u003e\nCardiac Resynchronization Stimulation for Heart Failure.pdf\u003cbr\u003e\nCardioneural Ablation to Prevent Bradyarrhythmias – Are We Ready for Prime Time..mp4\u003cbr\u003e\nCardioneural Ablation to Prevent Bradyarrhythmias – Are We Ready for Prime Time..pdf\u003cbr\u003e\nCase Presentations anel Discussion – Common Device Related Complications- How to Avoid Recognize Treat..mp4\u003cbr\u003e\nCase Presentations anel Discussion – Common Device Related Complications- How to Avoid Recognize Treat..pdf\u003cbr\u003e\nCase Presentations Panel Discussion- More Controversies and Frontiers in Managing Atrial Fibrillation – Part 2.mp4\u003cbr\u003e\nCase Presentations Panel Discussion- More Controversies and Frontiers in Managing Atrial Fibrillation – Part 2.pdf\u003cbr\u003e\nChallenging WPW Cases.mp4\u003cbr\u003e\nChallenging WPW Cases.pdf\u003cbr\u003e\nCO2 Insufflation for Epicardial Access- Tips and Tricks.mp4\u003cbr\u003e\nCO2 Insufflation for Epicardial Access- Tips and Tricks.pdf\u003cbr\u003e\nDebate- Left Atrial Occlusion Device is the Preferred Treatment Strategy to Prevent Bleeding and Strokes in Patients with Atrial Fibrillation 2.mp4\u003cbr\u003e\nDebate- Left Atrial Occlusion Device is the Preferred Treatment Strategy to Prevent Bleeding and Strokes in Patients with Atrial Fibrillation 2.pdf\u003cbr\u003e\nDebate- Left Atrial Occlusion Device is the Preferred Treatment Strategy to Prevent Bleeding and Strokes in Patients with Atrial Fibrillation.mp4\u003cbr\u003e\nDebate- Left Atrial Occlusion Device is the Preferred Treatment Strategy to Prevent Bleeding and Strokes in Patients with Atrial Fibrillation.pdf\u003cbr\u003e\nDemystifying Lead Extraction.mp4\u003cbr\u003e\nDemystifying Lead Extraction.pdf\u003cbr\u003e\nDrug Therapy for PVCs – Important considerations.mp4\u003cbr\u003e\nDrug Therapy for PVCs – Important considerations.pdf\u003cbr\u003e\nECG and Device Jeopardy.mp4\u003cbr\u003e\nECG and Device Jeopardy.pdf\u003cbr\u003e\nHow I Approach the Patient with SVT in the EP Lab – Pearls from Madrid.mp4\u003cbr\u003e\nHow I Approach the Patient with SVT in the EP Lab – Pearls from Madrid.pdf\u003cbr\u003e\nImaging to Improve Outcome of VT ablation.mp4\u003cbr\u003e\nImaging to Improve Outcome of VT ablation.pdf\u003cbr\u003e\nInappropriate Sinus Tachycardia.mp4\u003cbr\u003e\nInappropriate Sinus Tachycardia.pdf\u003cbr\u003e\nLessons Learned from Pacing and Programmed Stimulation During Reentrant Arrhythmias.mp4\u003cbr\u003e\nLessons Learned from Pacing and Programmed Stimulation During Reentrant Arrhythmias.pdf\u003cbr\u003e\nLessons Learned from Using ILRs in Patients Undergoing Afib Ablation.mp4\u003cbr\u003e\nLessons Learned from Using ILRs in Patients Undergoing Afib Ablation.pdf\u003cbr\u003e\nLV Summit PVC Ablation- What are the Challenges and How to Overcome..mp4\u003cbr\u003e\nLV Summit PVC Ablation- What are the Challenges and How to Overcome..pdf\u003cbr\u003e\nManagement of Arrhythmias in Patients with Oncologic Disease.mp4\u003cbr\u003e\nManagement of Arrhythmias in Patients with Oncologic Disease.pdf\u003cbr\u003e\nMy Favorite ECG Unknowns.mp4\u003cbr\u003e\nMy Favorite ECG Unknowns.pdf\u003cbr\u003e\nNot So Rare Restrictive Cardiomyopathies – Amyloidosis and Sarcoidosis.mp4\u003cbr\u003e\nNot So Rare Restrictive Cardiomyopathies – Amyloidosis and Sarcoidosis.pdf\u003cbr\u003e\nPacing to Improve Outcome in HEpEF Patients.mp4\u003cbr\u003e\nPacing to Improve Outcome in HEpEF Patients.pdf\u003cbr\u003e\nPanel Discussion- Case Presentations Highlighting the Use of Digital Health in EP.mp4\u003cbr\u003e\nPanel Discussion- Case Presentations Highlighting the Use of Digital Health in EP.pdf\u003cbr\u003e\nPanel Discussion- Programmed Stimulation, Drug Ablation Therapy and Imaging in the Management of VPDs (Case based presentation).mp4\u003cbr\u003e\nPanel Discussion- Programmed Stimulation, Drug Ablation Therapy and Imaging in the Management of VPDs (Case based presentation).pdf\u003cbr\u003e\nPersistent Atrial Fibrillation Ablation- What to Do Beyond PVI and in Which Patient.mp4\u003cbr\u003e\nPersistent Atrial Fibrillation Ablation- What to Do Beyond PVI and in Which Patient.pdf\u003cbr\u003e\nPulsed Field Ablation- Insights from Preclinical Studies.mp4\u003cbr\u003e\nPulsed Field Ablation- Insights from Preclinical Studies.pdf\u003cbr\u003e\nRadioablation for VT- Which Patients and Expected Outcomes..mp4\u003cbr\u003e\nRadioablation for VT- Which Patients and Expected Outcomes..pdf\u003cbr\u003e\nReversing Anticoagulation.mp4\u003cbr\u003e\nReversing Anticoagulation.pdf\u003cbr\u003e\nSinus Rhythm ECG Clues to Identify Risk and Origin of VT and VF in Nonischemic Cardiomyopathy and Unique VF Syndromes.mp4\u003cbr\u003e\nSinus Rhythm ECG Clues to Identify Risk and Origin of VT and VF in Nonischemic Cardiomyopathy and Unique VF Syndromes.pdf\u003cbr\u003e\nSOAAS23_Brochure_v8.pdf\u003cbr\u003e\nState of the Art Lecture (20 minute presentation + 5 min Q and A)- Role of MRI in Patients with PVCs.mp4\u003cbr\u003e\nState of the Art Lecture (20 minute presentation + 5 min Q and A)- Role of MRI in Patients with PVCs.pdf\u003cbr\u003e\nStatus of Risk Stratification for Identifying Potential for PVC cardiomyopathy.mp4\u003cbr\u003e\nStatus of Risk Stratification for Identifying Potential for PVC cardiomyopathy.pdf\u003cbr\u003e\nWhat’s HOT in Afib Pathophysiology and Treatment – Part 1.mp4\u003cbr\u003e\nWhat’s HOT in Afib Pathophysiology and Treatment – Part 1.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954625155170,"sku":"MED-AMB07047","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Penn-Medicine-The-Mark-E.-Josephson-Thirtieth-Annual-State-of-the-Art-Arrhythmia-Symposium-2023.jpg?v=1779381083","url":"https:\/\/meducourse.com\/products\/penn-medicine-the-mark-e-josephson-thirtieth-annual-state-of-the-art-arrhythmia-symposium-2023","provider":"Meducourse","version":"1.0","type":"link"}